
Pharmacally
Advanced RCC
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Advanced RCC
Clinical TrialsKura Reports Positive Phase 1a Data for Darlifarnib Plus Cabozantinib in Advanced RCCKura Oncology has reported encouraging Phase 1a FIT-001 results for darlifarnib plus cabozantinib in cabozantinib-naïve patients with advanced clear cell renal cell carcinoma.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.